William Newhard

The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function

Genevieve Clutton, Yinyan Xu, Pedro L. Baldoni et al. · Scientific Reports · 2016 · 72 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection

A Howe, Stuart Black, Stephanie Curry et al. · Clinical Infectious Diseases · 2014 · 36 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Emergence of resistance-associated variants after failed triple therapy with vaniprevir in treatment-experienced non-cirrhotic patients with hepatitis C-genotype 1 infection: A population and clonal analysis

Richard J. O. Barnard, Carolyn McHale, William Newhard et al. · Virology · 2013 · 20 citations

Life Sciences, Molecular Genetics, Pharmacotherapy +17

Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation

Sai Vikram Vemula, Jill W. Maxwell, Alexey Nefedov et al. · Antiviral Research · 2016 · 20 citations

Life Sciences, Molecular Biology, Pharmacology +13

Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel<i>In Vitro</i>Pharmacodynamic System

Ashley N. Brown, James J. McSharry, Jonathan Adams et al. · Antimicrobial Agents and Chemotherapy · 2011 · 14 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17